BioCorRx (BICX) Non-Current Assets (2011 - 2026)

BioCorRx has disclosed Non-Current Assets across 16 years of filings, most recently posting $1.3 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $1.3 million, down 79.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.9 million (up 109.32% YoY), and the FY2025 annual result was $1.3 million, up 397.39% from the prior year.
• Non-Current Assets came in at $1.3 million for Q1 2026 at BioCorRx, down from $1.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.2 million in Q1 2025 to a low of $165851.0 in Q1 2024.
• The 5-year median for Non-Current Assets is $449684.0 (2022), against an average of $1.5 million.
• Across the five-year window, Non-Current Assets surged 3659.57% in 2025 and slumped 79.08% in 2026, its largest moves.
• BioCorRx's Non-Current Assets stood at $449684.0 in 2022, then plunged by 55.13% to $201768.0 in 2023, then soared by 32.8% to $267945.0 in 2024, then surged by 397.39% to $1.3 million in 2025, then retreated by 2.11% to $1.3 million in 2026.
• The last three Non-Current Assets figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.